-
Jan 7, 2025 | 
onlinelibrary.wiley.com | Peng Yun Chen |Lu Wang |Xuan Wang |Jie Sun
Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
-
Oct 30, 2024 | .html&sz=64)
fis.tu-dresden.de | Lei Wei |Peng Yun Chen |Yu Mei |Jian Sun
A hierarchical control framework for alleviating network traffic bottleneck congestion using vehicle trajectory dataResearch output: Contribution to journal › Research article › Contributed › peer-review
-
Sep 2, 2024 | 
mdpi.com | Peng Yun Chen |Hui Zhou |Ying Li |Bingxin Liu
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jul 31, 2024 | 
nature.com | Ran Zuo |zhiyong Liu |Peng Yun Chen |Yuchao He
AbstractResistance to epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors (TKIs) is a significant cause of treatment failure and cancer recurrence in non-small cell lung cancer (NSCLC). Approximately 30% of patients with EGFR-activating mutations exhibit primary resistance to EGFR–TKIs. However, the potential mechanisms of primary resistance to EGFR–TKIs remain poorly understood.
-
Jul 31, 2024 | 
mdpi.com | Xinyu Hou |Peng Yun Chen
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
May 6, 2024 | 
ascpt.onlinelibrary.wiley.com | Peng Yun Chen |Yanyan Zhang |Yike Wang |Ke Ma
WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Adebrelimab, a novel anti-PD-L1 antibody, has been approved by the National Medical Products Administration (NMPA) of China as an intravenous infusion for use in combination with carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (ES-SCLC). Adebrelimab is administered currently at a body weight-based dose of 20 mg/kg q3w. WHAT QUESTION DID THIS STUDY ADDRESS?
-
Feb 10, 2024 | 
onlinelibrary.wiley.com | Shulin Jiao |Xiaofan Sun |Min Zhao |Peng Yun Chen
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description smll202310768-sup-0001-SuppMat.pdf1.4 MB Supporting Information smll202310768-sup-0002-VideoS1.mp45.2 MB Supplemental Video 1 smll202310768-sup-0003-cif.zip134.9 KB Supporting Information References 1Nat. Mater. 2023, 22, 525. 2, , , , Nat. Rev. Mater. 2023, 8, 355. 3, , , , , , , , , Nano Lett. 2023, 23, 7419. 4, , , , , , , , , Small 2021, 17, 2006021.
-
Nov 29, 2023 | 
onlinelibrary.wiley.com | Dongxu He |Nanotechnology The |Peng Yun Chen |Mengmeng Hao
Introduction Narrow-band gap tin-lead mixed (Sn−Pb) perovskite solar cells (PSCs) are attracting increasing attention for their potential in the development of efficient monolithic all-perovskite tandem devices1-7 that possess the advantages of low manufacturing cost, all-solution processes, flexible substrate compatibility and lightweight over their Si-perovskite counterparts.8, 9 Nonetheless, the practical implementation of Sn−Pb PSCs is hampered by the easy oxidation of Sn2+ to Sn4+ under...
-
Nov 1, 2023 | 
onlinelibrary.wiley.com | Peng Yun Chen |Central South Changsha |Ji Li |Ziye Yang
Corresponding Author Ziye Yang Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China Hunan Key Laboratory of Aging Biology, Xiangya Hospital, Central South University, Changsha, China National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China Correspondence Yi Xiao Email: [email protected], Xiang Chen Email: [email protected] and Ziye Yang Email: [email protected], Department of...
-
Sep 22, 2023 | 
hindawi.com | Peng Yun Chen |Ying Tang |Xiao Tang |Alex Molassiotis |M. Tish Knobf |Guang Hu | +3 more
Background. Prediction of high-risk depression trajectories in the first year following breast cancer diagnosis with fMRI-related brain connectomics is unclear. Methods. The Be Resilient to Breast Cancer (BRBC) study is a multicenter trial in which 189/232 participants (81.5%) completed baseline resting-state functional magnetic resonance imaging (rs-fMRI) and four sequential assessments of depression (T0-T3).
